Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GLUE compared with SVRA: revenue, margins and what each company keeps, and the suppliers and customers both name
GLUE
Monte Rosa Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SVRA
Savara Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
GLUE
Monte Rosa Therapeutics, Inc.
vs
SVRA
Savara Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
GLUE
with
SVRA
Uncorrelated: r 0.19 · 499D.
Shared co-movers
1
with GLUE
with SVRA
NRIX
Nurix Therapeutics, Inc.
r 0.31
r 0.33
GLUE, solid
SVRA, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
GLUE
Monte Rosa Therapeutics, Inc.
Change
10.76
▼
−1.02%
· post 10.60
Mkt cap
$918.0M
Revenue
$9M
Q2 FY26
Revenue
$124M
FY25
SVRA
Savara Inc
Change
4.83
▼
−2.53%
· post 4.83
Closed
Oct 30 '26
Mkt cap
$990.3M
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
GLUE
Monte Rosa Therapeutics, Inc.
vs
SVRA
Savara Inc
10.76
▼
−1.02%
post 10.60
Price
4.83
▼
−2.53%
post 4.83
$918.0M
Mkt cap
$990.3M
Q2 FY26
$9M
Revenue
—
FY25
$124M
Revenue
—
Change
Change
GLUE
10.76
▼
−1.02%
vs
SVRA
4.83
▼
−2.53%
Closed
Oct 30 '26